Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Christopher Harrod"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/59d3559dce604a06a55f85574c1e2118
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/0f0969d54a584d7ca5b57dab0566287c
Publikováno v:
Cancer Research. 83:1722-1722
Mutation-targeting therapies have become a transformative technology and in many ways a new paradigm for cancer treatment for patients. The early development of Erlotinib for non-small cell lung cancer paved the way for EGFR treatment, irrespective o
Publikováno v:
Cancer Research. 82:1880-1880
High throughput screening offers tangible benefits towards rapidly testing various permutations of novel or existing therapeutic agents. In particular, tumor panels that cover a range of histotypes and molecular subtypes have been previously develope
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCancer immunotherapy represents a burgeoning new direction for oncology therapeutic innovation, with the principal thesis of activating one’s own immune system to irradicate cancer as opposed to the injection of foreign cytotoxic agents l
Autor:
Todd Albert, Christopher Harrod
Publikováno v:
Complex Spine Cases: A Collection of Current Techniques
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acd1d264d9f58f6bcf1cd652f809b53f
https://doi.org/10.5005/jp/books/12554_42
https://doi.org/10.5005/jp/books/12554_42
Publikováno v:
Toyota Motor Corporation Australia Limited MarketLine Company Profile. 12/5/2019, p1-18. 18p.
Publikováno v:
Toyota Motor Corporation Australia Limited MarketLine Company Profile. 2/9/2018, p1-17. 17p.
Publikováno v:
Toyota Motor Corporation Australia Limited MarketLine Company Profile. 2/24/2017, p1-15. 16p.
Publikováno v:
Toyota Motor Corporation Australia Limited MarketLine Company Profile. 5/25/2016, p1-16. 17p.